|
000
| 01935nam 2200385zi 4500 |
|---|
| 001 | 9.878403 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107165230 |
|---|
| 006 | m o d f |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 190822e20190621onc ob f000 0 eng d |
|---|
| 020 | |a9781775017073 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH164-195/1-2019E-PDF |
|---|
| 245 | 00|aGood label and package practices guide for prescription drugs. |
|---|
| 264 | 1|aOttawa : |bHealth Canada = Santé Canada, |cJune 21, 2019. |
|---|
| 264 | 4|c©2019 |
|---|
| 300 | |a1 online resource (iii, 73 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Guide des bonnes pratiques d’étiquetage et d’emballage pour les médicaments sur ordonnance. |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 504 | |aIncludes bibliographical references (pages 55-68). |
|---|
| 520 | |a"The objective of the Good Label and Package Practices Guide for Prescription Drugs is to provide direction to sponsors, manufacturers and license holders (to be referred to as ‘sponsors’ within this guide) in designing safe and clear labels and packages"--Objective, page 1. |
|---|
| 692 | 07|2gccst|aPrescription drugs |
|---|
| 692 | 07|2gccst|aDrug labelling |
|---|
| 692 | 07|2gccst|aPackaging |
|---|
| 710 | 1 |aCanada. |bHealth Canada. |
|---|
| 710 | 2 |aThe Institute for Safe Medication Practices Canada. |
|---|
| 775 | 08|tGuide des bonnes pratiques d'étiquetage et d'emballage pour les médicaments sur ordonnance.|w(CaOODSP)9.878404 |
|---|
| 856 | 40|qPDF|s1.34 MB|uhttps://publications.gc.ca/collections/collection_2019/sc-hc/H164-195-1-2019-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/reports-publications/medeffect-canada/good-label-package-practices-guide-prescription-drugs-profile.html |
|---|